Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-11

Clinical Trial Update: A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a freeze-dried rabies vaccine (MRC-5 cells) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MRC-5 cell-based rabies vaccine (rabies vaccine)

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Rabies Vaccine Adverse Reaction | Phase 3 | Status: COMPLETED